Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Histopathology ; 72(7): 1115-1127, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29314151

ABSTRACT

AIMS: The aim of the present study was to compare treated lymphoma-associated Epstein-Barr virus (EBV)-positive mucocutaneous ulcer (EBVMCU) and methotrexate (MTX)-associated EBVMCU. METHODS AND RESULTS: Of a series of 15 Japanese patients (11 women, four men; median age 74 years, range 35-84 years), seven received MTX for the treatment of autoimmune disease and eight developed EBVMCU after treatment of malignant lymphoma [diffuse large B-cell lymphoma (n = 4) without EBV association, adult T-cell leukaemia/lymphoma (n = 2), angioimmunoblastic T-cell lymphoma (n = 1), and follicular lymphoma (n = 1)]. Ulcers were observed in the oral cavity (n = 11), gastrointestinal tract (n = 2), and skin (n = 2). All were histologically characterised by a mixture of EBV-positive large B-cell proliferation and Hodgkin/Reed-Sternberg-like cells on a polymorphous background. A total of 46% (6/13) had monoclonal immunoglobulin heavy chain gene rearrangement, but none had clonal T-cell receptor gene rearrangement. Spontaneous regression occurred in 13 of 15 cases (87%); the other two cases (13%) achieved complete remission after treatment. Of two patients in the treated lymphoma-associated subgroup, one developed multiple new ulcerative lesions on previously unaffected skin, and the other had a relapse of EBVMCU in the oral cavity. No significant clinicopathological differences were found between the subgroups. Notably, none of the patients died from EBVMCU. However, the treated lymphoma-associated subgroup had lower overall survival (P = 0.004) and a shorter follow-up period (P = 0.003) than the MTX-associated subgroup, owing to death from non-associated causes. CONCLUSIONS: Treated lymphoma-associated EBVMCU, which is an indolent and self-limited condition, must be recognised to avoid misdiagnosing it as a relapse of malignant lymphoma during treatment.


Subject(s)
Epstein-Barr Virus Infections/etiology , Immunosuppressive Agents/adverse effects , Lymphoma/complications , Methotrexate/adverse effects , Ulcer/etiology , Adult , Aged , Aged, 80 and over , Autoimmune Diseases/drug therapy , Epstein-Barr Virus Infections/virology , Female , Humans , Immunosuppressive Agents/therapeutic use , Japan , Male , Methotrexate/therapeutic use , Middle Aged , Ulcer/virology
3.
Intern Med ; 54(13): 1657-60, 2015.
Article in English | MEDLINE | ID: mdl-26134201

ABSTRACT

A 16-year-old boy stayed in Tokyo near Yoyogi Park for extracurricular high school activities. After returning home, he experienced an episode of fever and visited our emergency outpatient unit. He initially exhibited symptoms of leukopenia, thrombocytopenia and concomitant rhabdomyolysis and after admission simultaneously developed a biphasic fever and systemic erythema. Based on the results of reverse transcription polymerase chain reaction testing, he was finally diagnosed with dengue fever. After an absence of 70 years, dengue fever has reemerged as a domestic infection. Awareness of this trend led to our diagnosis.


Subject(s)
Dengue Virus/drug effects , Dengue/complications , Dengue/diagnosis , Rhabdomyolysis/diagnosis , Rhabdomyolysis/virology , Thrombocytopenia/drug therapy , Adolescent , Dengue/drug therapy , Dengue/pathology , Dengue Virus/isolation & purification , Emergency Treatment , Fever/virology , Hospitalization , Humans , Male , Rhabdomyolysis/complications , Rhabdomyolysis/drug therapy , Thrombocytopenia/complications , Tokyo
SELECTION OF CITATIONS
SEARCH DETAIL
...